CLINICAL_TRIALS
trial_result
· 2011-05-13
Clinical Trial Update: Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) [Phase 4]
Summary
Phase 4 post-marketing study of cilostazol for stroke prevention in patients with cerebral infarction; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Cerebral Infarction | Phase 4 | Status: COMPLETED | Results posted: 2011-05-13